Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Diffusing lung capacity (DLCO) in cured asthmatic children (CROSBI ID 632587)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Pavlov, Neven ; Tocilj, Jadranka ; Dragišić-Ivulić, Slavica ; Balarin, Livio Diffusing lung capacity (DLCO) in cured asthmatic children // The European respiratory journal. Supplement / European Respiratory Society (ur.). 1998. str. 43-43

Podaci o odgovornosti

Pavlov, Neven ; Tocilj, Jadranka ; Dragišić-Ivulić, Slavica ; Balarin, Livio

engleski

Diffusing lung capacity (DLCO) in cured asthmatic children

High percentage of uncured asthmatic children have the increased diffusion lung capacity (DLCO). One of the explanations is that asthma as a chronic inflammatory disorder of airways, by increasing the permeability of alveolocapillary membrane, can cause the increase of diffusion lung capacity. The Aim: To determine value of parameters obtained by the measurement of DLCO within the group of healthy children (Control) and in the asthmatic groups under the various therapies: Inhaled steroid (IS: fluticasone propionate 100-200 µg daily, Specific immunotherapy (SIT) and Sodium cromoglicate (SC: 60-80 µg daily) group. Subjects and Methods: In 161 children (96 boys and 65 girls) diagnosed as mild and moderate asthma and 40 healthy children (20 boys and 20 girls), we measured: DLCO (Single breath method with carbon monoxide, measured with Masterlab Jaeger), Residual volume (RV) and Residual volume percentage of the total lung capacity (RV%TLC). In Statistic Analysis: the Oneway analysis of variance, Mann-Whitney and Chi-square tests were used. The Results were as follows: Control IS SIT SC p No. of children (201) 40 86 48 25 Age (y) 11.1 ± 2.2 9.7 ± 3.2 10.8 ± 3.6 11.4 ± 3 Therapy (y) 0 1.6 ± 1.8 3.6 ± 1.6 2.3 ± 1.9 DLCO (%) 106 ± 20 118 ± 30 126 ± 34 134 ± 55 0.076 RV (%) 150 ± 70 267 ± 127 247 ± 175 255 ± 143 0.001 RV%TLC (%) 139 ± 47 184 ± 40 180 ± 59 184 ± 52 0.002 Results reported as average ± standard deviation. DLCO: expressed as percentage of predicted value according to Cotes, RV and RV%TLC: percentage of predicted value according to Zapletal. There were no statistically significant differences of DLCO values among the Control and other examined groups. IS, SIT and SC groups did not differ in parameters: RV and RV%TLC, while this difference was statistically significant in relation to the Control group. Conclusion: In cured asthmatic children the significant increase of DLCO was not proved. Parameter pointing to the hyperinflation (RV and RV%TLC) in comparison with the Control group were statistically significantly increased. RV and RV%TLC normalisation suggests the complete remission of disease.

DLCO; hyperinflation; asthma; children

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

43-43.

1998.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

The European respiratory journal. Supplement

European Respiratory Society

Barcelona: European Respiratory Society

0904-1850

Podaci o skupu

World Asthma Meeting

poster

10.12.1998-15.12.1998

Barcelona, Španjolska

Povezanost rada

Kliničke medicinske znanosti

Indeksiranost